Dalia Mahmoud

Dalia Mahmoud is a seasoned executive with extensive experience in global market access and pricing strategies, currently serving as VP Head of International Market Access and Pricing and US IRA Strategy and Negotiation Teams at AbbVie since September 2018. Previous roles at AbbVie include VP and Head of Global Market Access and Pricing and VP Head of Global Market Access and Pricing for both Immunology and Oncology sectors. Prior to AbbVie, Dalia held the position of Executive Director at Celgene, focusing on global pricing and market access in hematology oncology. Dalia's career also includes roles at Roche as International Economic Strategy Leader, IMS Consulting as Senior Consultant, and Medco as Manager Client Strategies. Dalia began with a foundation in technology as a Product Manager at ALK Technologies and has a strong academic background, holding degrees from Princeton University and an MBA from Columbia Business School.